CD37 is broadly and selectively expressed on tumor cells from B-cell malignancies, including CLL cells, where it is involved in various biological processes such as cell adhesion, proliferation, survival, and trafficking [as reviewed in (223)]. This evidence concerns the gene CD37 and B-cell chronic lymphocytic leukemia.